GlassScriptPhysician profile
Sara Kaniper
NPI 1407329923
$1,484.34
in general payments reported to CMS, 2019-2025
9 companies · $792 in 2025
The $792 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $289 · 2022: $163 · 2023: $86.22 · 2024: $154 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $526 · Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $525.66 |
| Food and Beverage | $506.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,171.55 | 2021-2025 | Vasoview Hemopro 2, Heartstring III Proximal Seal, Vasoview Hemopro 2 |
| Abiomed | $101.97 | 2022 | |
| Ethicon US, LLC | $56.92 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix |
| Atricure, INC. | $48.71 | 2025 | Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
| Convatec INC. | $30.03 | 2024 | |
| Medtronic, INC. | $25.51 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.08 | 2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $17.20 | 2022 | |
| Edwards Lifesciences Corporation | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Kaniper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.